This information is for educational purposes only. Always consult a healthcare professional. Learn more
Drug Economics & Access · 8 min read

Understanding Drug Insurance Coverage

Formularies, tiers, prior authorizations, step therapy, and deductibles: insurance coverage for prescription drugs is complicated. This guide decodes the system and explains how to work within it effectively.

How Prescription Drug Coverage Works

Prescription drug benefits — whether through an employer-sponsored health plan, an Affordable Care Act marketplace plan, or Medicare Part D — share a common architecture. A pharmacy benefit manager (PBM) contracts with the insurance plan to manage drug benefits. The PBM negotiates prices with manufacturers, maintains a list of covered drugs (the formulary), and processes pharmacy claims.

When you present your insurance card at the pharmacy, the pharmacist submits a claim to your PBM in real time. The PBM checks whether the drug is on the formulary, what tier it is on, whether prior authorization is required, whether you have met your deductible, and what your cost-sharing obligation is. All of this happens in seconds.

Understanding this system helps you anticipate coverage decisions, prepare for appeals, and make informed choices when you have options.

Formularies and Tiers

A formulary is the list of drugs covered by your insurance plan. Not every drug is on every formulary; coverage decisions are made by the plan's pharmacy and therapeutics (P&T) committee, which weighs clinical evidence, cost-effectiveness, and the rebates manufacturers offer.

Most formularies organize covered drugs into tiers, with your cost-sharing obligation increasing as you move up the tier structure. A typical commercial plan might look like this:

  • Tier 1 (Generic): Lowest copay, often $0–$10 per fill. Preferred generics that the plan has contracted at favorable prices.
  • Tier 2 (Preferred Brand): Higher copay, often $30–$50. Brand-name drugs for which the manufacturer offers significant rebates to the plan.
  • Tier 3 (Non-Preferred Brand): Even higher copay, often $60–$100. Brand-name drugs or generics with less favorable rebate terms.
  • Tier 4 (Specialty): Highest cost-sharing, often 20–30% coinsurance (a percentage of the drug cost rather than a flat copay). Specialty drugs — biologics, cancer drugs, and other complex medications — typically land here and can generate four-figure monthly out-of-pocket costs.

Formularies change annually. Your plan is required to notify you of significant mid-year changes, and you can request a non-formulary exception if clinical circumstances warrant.

Prior Authorization

Prior authorization (PA) is a requirement that your insurer approve a medication before it will cover the cost. PAs are used for expensive drugs, drugs with abuse potential, or medications where the plan wants to verify that a particular patient's circumstances warrant that specific therapy.

To obtain a PA, your prescriber submits documentation to the insurer or PBM — typically a completed form explaining the diagnosis, the medications tried previously, and why the requested drug is medically necessary. The process can take 1–14 business days. During this time, you may not be able to fill the prescription at the covered price.

Tips for navigating PA:

  • Ask your prescriber's office to submit the PA as soon as the prescription is written, not after you've encountered a rejection at the pharmacy.
  • Many insurers have electronic PA submission portals that are faster than fax.
  • If you need the medication urgently, ask your prescriber about a PA expedite request or an emergency supply from the pharmacist.
  • Manufacturer copay cards can sometimes bridge the gap while the PA is pending.

Step Therapy

Step therapy (also called "fail first") requires that a patient try and fail one or more lower-cost medications before the insurer will cover the requested drug. For example, a plan might require that you try two generic antidepressants before approving a brand-name that your prescriber prefers.

Step therapy is based on the principle that many patients respond adequately to first-line generic medications, and expensive alternatives should be reserved for those who genuinely need them. Critics argue that it delays effective treatment, especially when the patient's condition or medical history makes it clinically obvious that the preferred first-line medication is inappropriate.

Most states have enacted step therapy reform laws that require insurers to grant exceptions when a patient has already failed a required step-therapy drug, when the required drug is contraindicated, or when the prescriber documents a compelling clinical reason to skip steps. Know your state's law and use it if your prescriber supports a step-therapy exception.

Quantity Limits

Quantity limits restrict how much of a medication can be dispensed per fill or per month. For example, a plan might cover 30 tablets of a migraine medication per month, or 12 inhalers per year. These limits are designed to prevent overuse of medications with abuse potential or to align dispensing with expected clinical use.

If your clinical circumstances require quantities exceeding the plan's limit — for example, you have more frequent migraines than the standard limit accommodates — your prescriber can document medical necessity and request a quantity limit exception. Exceptions are routinely granted when appropriately documented.

Deductibles, Copays, and Coinsurance

Your cost-sharing structure determines how much you pay for each prescription:

  • Deductible: The amount you must pay out of pocket each year before your insurance begins paying its share. Many plans have a separate, lower deductible for generic drugs. Until you meet your deductible, you may pay the full negotiated price (not the list price) for each medication.
  • Copay: A fixed dollar amount per prescription fill (e.g., $10 for generics, $45 for preferred brands). Copays apply after the deductible is met.
  • Coinsurance: A percentage of the drug cost you pay (e.g., 20% of the drug cost for specialty medications). Coinsurance can result in very high out-of-pocket costs for expensive drugs.
  • Out-of-pocket maximum: The most you will pay in a calendar year. After reaching this cap, your insurance covers 100% of covered drug costs.

For patients on specialty medications, understanding the interplay of deductible, coinsurance, and out-of-pocket maximum is essential for financial planning. Specialty pharmacies assigned to handle these drugs often have financial counselors who can help.

How to Appeal a Coverage Denial

You have the right to appeal any coverage denial. The appeals process involves several levels:

  1. Internal appeal: Request a review by the insurer's medical staff. You and your prescriber can submit additional documentation supporting medical necessity.
  2. Expedited appeal: If waiting for the standard review timeline would seriously jeopardize your health, you can request an expedited review (typically within 72 hours).
  3. External review: If the internal appeal is denied, you can request an independent external review by a third party not affiliated with the insurer. For most plans, the external reviewer's decision is binding on the insurer.
  4. State Insurance Commissioner: If the external review is denied or the process is not followed correctly, file a complaint with your state's insurance regulatory agency.

Appeals are more likely to succeed when your prescriber provides a detailed letter of medical necessity, including your diagnosis, the clinical rationale for the specific drug, the contraindications or failures of alternatives, and references to clinical guidelines.

Medicare Part D Specifics

Medicare Part D (prescription drug coverage) has its own cost structure that differs from commercial insurance:

  • Coverage Gap ("Donut Hole"): After your total drug spending reaches an initial coverage limit, you enter the coverage gap, where your cost-sharing is higher. Manufacturers are required to provide discounts on brand-name drugs during the gap.
  • Catastrophic Coverage: After a spending threshold is reached, cost-sharing drops significantly.
  • Extra Help / Low Income Subsidy (LIS): A federal program that substantially reduces Part D premiums, deductibles, and copays for qualifying low-income beneficiaries. If you have limited income and assets, check your eligibility — over 3 million people who qualify do not receive it.
  • Annual Plan Review: Part D plans change their formularies each year. Review your plan's annual notice of change every fall during open enrollment (October 15 – December 7) to confirm your medications remain covered at affordable tiers.

Understanding your plan's architecture — and your rights within it — can save you thousands of dollars annually and ensure you receive the medications your prescriber has determined are right for you.

This guide is for educational purposes only. It does not replace professional medical advice. Always consult your healthcare provider before making changes to your medication regimen.

Related Glossary Terms

Try These Tools